🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To confirm the tolerability and safety of combined administration of ONO-79...
Status
Active Not Recruiting
Location
Fujita Health University Hospital
Start Date
2021-09-23
Trial ID
NCT06540261
Treatments Being Tested
This phase Ib/II trial identifies the best dose and possible benefits and/o...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-04-06
Trial ID
NCT04541017
Background: B-cell lymphoma is a cancer of certain white blood cells (call...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2021-12-16
Trial ID
NCT04599634
This phase I/Ib trial studies the side effects and best dose of Hu5F9-G4 (m...
Status
Withdrawn
Location
UC Irvine Health Cancer Center-Newport
Start Date
2024-03-05
Trial ID
NCT05807126
Treatments Being Tested
To assess the tolerability, safety, and pharmacokinetics (PK) of ONO-7913 i...
Status
Completed
Location
Local Institution
Start Date
2020-07-28
Trial ID
NCT04403308
Treatments Being Tested
This phase I trial is to find out the best dose, possible benefits and/or s...
Status
Terminated
Location
Children's Hospital Los Angeles
Start Date
2021-08-31
Trial ID
NCT04751383
To investigate the tolerability and safety of ONO-7913 and ONO-4538 used in...
Status
Active Not Recruiting
Location
National Cancer Center Hospital East
Start Date
2021-07-30
Trial ID
NCT06532344
Treatments Being Tested
The purpose of this study is to test the safety and efficacy of magrolimab ...
Status
Terminated
Location
Stanford University
Start Date
2022-06-21
Trial ID
NCT04788043
Treatments Being Tested